Peptides to Overcome the Limitations of Current Anticancer and Antimicrobial Nanotherapies

Biomedical research devotes a huge effort to the development of efficient non-viral nanovectors (NV) to improve the effectiveness of standard therapies. NVs should be stable, sustainable and biocompatible and enable controlled and targeted delivery of drugs. With the aim to foster the advancements o...

Descripción completa

Detalles Bibliográficos
Autores principales: Del Genio, Valentina, Bellavita, Rosa, Falanga, Annarita, Hervé-Aubert, Katel, Chourpa, Igor, Galdiero, Stefania
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9230615/
https://www.ncbi.nlm.nih.gov/pubmed/35745807
http://dx.doi.org/10.3390/pharmaceutics14061235

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9230615/
https://www.ncbi.nlm.nih.gov/pubmed/35745807
http://dx.doi.org/10.3390/pharmaceutics14061235

Ejemplares similares